Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (CSE:PHRX)

PharmaDrug Announces Issuance of Debenture Units

Newsfile November 15, 2024

PharmaDrug Announces Proposed Issuance of Debenture Units

Newsfile October 31, 2024

PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases

Newsfile October 31, 2024

PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Newsfile September 19, 2024

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Newsfile August 28, 2024

PharmaTher's Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

GlobeNewswire August 21, 2024

PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

Newsfile August 21, 2024

PharmaTher's Sairiyo Therapeutics Receives Approval to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)

GlobeNewswire August 19, 2024

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Newsfile August 19, 2024

Opinion & Analysis (CSE:PHRX)

No current opinion is available.

Bullboard Posts (CSE:PHRX)

Silence

Quiet on the news front. Can we expect any news before the holidays, and Merry Christmas to all.
Tommyjohn - December 4, 2024

Selling

What's with the sell off today
Tommyjohn - November 20, 2024

RE:RE:RE:New debenture raise..to replace current debenture..!

Wow, great information, I really appreciate the insight.
Tommyjohn - November 1, 2024

RE:RE:New debenture raise..to replace current debenture..!

Markets play to their own tune. Typical market trading moves bringing in substantial buying volume and later retraces back to its start...
Guytorule - October 31, 2024

RE:New debenture raise..to replace current debenture..!

Yes, does seem like good news, but are they not still short on cash. Still can't figure out the spike a few months back, just to fall...
Tommyjohn - October 31, 2024

New debenture raise..to replace current debenture..!

Good news, just released new debenture raise to replace current outstanding debenture due. Conversion possible within 1 year at a share...
Guytorule - October 31, 2024